• Latest Posts

Ablynx gain €2.1m to develop a novel Nanobodies for Ocular applications

GSK abandon its joint drug project with Galapagos

Sanofi buy Mannkind’s inhaled insulin for $925m

ProQR Therapeutics files for a $75m IPO to compete with Vertex Pharmaceuticals

Active Biotech and Teva together in a Phase II clinical trial against Huntington’s disease

Relive BIO 2014, the World’s Biggest Biotech Convention

ADVERTISEMENT

Discover Hello Tomorrow Challenge, European largest technological start-up challenge

ADVERTISEMENT